Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-06-14 Sale |
2023-06-16 4:48 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
9,000 | $18.58 | $167,220 | 1,039,603 (Indirect Direct) |
View |
2023-06-08 Sale |
2023-06-12 5:40 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
3,100 | $20.01 | $62,031 | 1,041,756 (Indirect Direct) |
View |
2023-06-08 Sale |
2023-06-12 5:25 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
100 | $20 | $2,000 | 48,086 (Direct) |
View |
2023-06-06 Sale |
2023-06-08 7:16 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
4,643 | $19 | $88,231 | 48,186 (Direct) |
View |
2023-05-17 Sale |
2023-05-19 7:08 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
8,000 | $15.9 | $127,200 | 1,051,703 (Indirect Direct) |
View |
2023-05-10 Sale |
2023-05-12 5:08 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
9,000 | $16.8 | $151,200 | 1,059,703 (Indirect Direct) |
View |
2023-04-28 Sale |
2023-05-02 7:06 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
10,119 | $15.11 | $152,925 | 1,068,703 (Indirect Direct) |
View |
2023-04-21 Sale |
2023-04-25 5:22 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
2,311 | $15.03 | $34,734 | 1,078,822 (Indirect Direct) |
View |
2023-04-20 Sale |
2023-04-21 5:53 pm |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
5,000 | $14.02 | $70,100 | 26,785 (Direct) |
View |
2023-04-19 Sale |
2023-04-21 5:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
8,000 | $13.6 | $108,800 | 1,081,133 (Indirect Direct) |
View |
2023-03-21 Sale |
2023-03-23 8:04 pm |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
1,004 | $12.55 | $12,603 | 31,785 (Direct) |
View |
2023-03-21 Sale |
2023-03-23 8:02 pm |
Tarsus Pharmaceuticals Inc. | TARS | Trevejo Jose M. CHIEF MEDICAL OFFICER |
1,513 | $12.58 | $19,026 | 6,107 (Direct) |
View |
2023-03-21 Sale |
2023-03-23 7:56 pm |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
1,141 | $12.55 | $14,324 | 54,696 (Direct) |
View |
2023-03-21 Sale |
2023-03-23 7:52 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
1,078 | $12.55 | $13,532 | 16,402 (Direct) |
View |
2023-03-21 Sale |
2023-03-23 7:50 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
2,125 | $12.55 | $26,669 | 1,089,133 (Indirect Direct) |
View |
2023-03-21 Sale |
2023-03-23 7:48 pm |
Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer |
1,004 | $12.55 | $12,603 | 11,219 (Direct) |
View |
2023-03-21 Sale |
2023-03-23 7:46 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
1,078 | $12.55 | $13,531 | 52,829 (Direct) |
View |
2023-03-17 Sale |
2023-03-21 7:17 pm |
Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer |
649 | $12.94 | $8,396 | 12,223 (Direct) |
View |
2023-03-17 Sale |
2023-03-21 7:14 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
696 | $12.94 | $9,004 | 17,480 (Direct) |
View |
2023-03-17 Sale |
2023-03-21 7:12 pm |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
740 | $12.94 | $9,573 | 55,837 (Direct) |
View |
2023-03-17 Sale |
2023-03-21 7:10 pm |
Tarsus Pharmaceuticals Inc. | TARS | Trevejo Jose M. CHIEF MEDICAL OFFICER |
1,034 | $12.94 | $13,376 | 7,620 (Direct) |
View |
2023-03-17 Sale |
2023-03-21 7:08 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
697 | $12.94 | $9,016 | 53,907 (Direct) |
View |
2023-03-17 Sale |
2023-03-21 7:06 pm |
Tarsus Pharmaceuticals Inc. | TARS | Holdbrook Mark J. V.P., Clinical Affairs |
386 | $12.94 | $4,993 | 3,191 (Direct) |
View |
2023-03-17 Sale |
2023-03-21 7:03 pm |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
649 | $12.94 | $8,396 | 32,789 (Direct) |
View |
2023-03-17 Sale |
2023-03-21 7:01 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair |
1,536 | $12.96 | $19,902 | 1,091,258 (Indirect Direct) |
View |
2023-03-16 Sale |
2023-03-17 6:22 pm |
Tarsus Pharmaceuticals Inc. | TARS | Holdbrook Mark J. V.P., Clinical Affairs |
187 | $13.43 | $2,511 | 11,536 (Direct) |
View |
2023-03-16 Sale |
2023-03-17 6:21 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
337 | $13.43 | $4,526 | 32,546 (Direct) |
View |
2023-03-16 Sale |
2023-03-17 6:20 pm |
Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer |
313 | $13.43 | $4,204 | 26,260 (Direct) |
View |
2023-03-16 Sale |
2023-03-17 6:18 pm |
Tarsus Pharmaceuticals Inc. | TARS | Trevejo Jose M. Chief Medical Officer |
499 | $13.43 | $6,702 | 31,302 (Direct) |
View |
2023-03-16 Sale |
2023-03-17 6:17 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
336 | $13.43 | $4,512 | 68,974 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-06-16 Exercise |
2023-06-21 6:25 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | CHAUDHURI BHASKAR Director |
2,000 | $0 | 2,000 (Direct) |
View |
2023-06-16 Exercise |
2023-06-21 6:21 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director |
2,000 | $0 | 2,000 (Direct) |
View |
2023-06-16 Exercise |
2023-06-21 6:18 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
2,000 | $0 | 2,000 (Direct) |
View |
2023-06-16 Exercise |
2023-06-21 6:14 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Director |
2,000 | $0 | 20,400 (Direct) |
View |
2023-06-16 Exercise |
2023-06-21 6:08 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
2,000 | $0 | 136,632 (Direct) |
View |
2023-05-11 Other |
2023-05-15 5:57 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
256,795 | $0 | 501,319 (Indirect) |
View |
Ownership(A) |
2023-04-28 8:01 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
0 | $0 | 700 (Direct) |
View |
2023-04-24 Option Award |
2023-04-26 5:05 pm |
N/A 2033-04-23 |
Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks |
274,922 | $0 | 274,922 (Direct) |
View |
2023-03-15 Other |
2023-03-17 6:39 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
267,769 | $0 | 471,074 (Indirect) |
View |
2023-03-15 Exercise |
2023-03-17 6:22 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Holdbrook Mark J. V.P., Clinical Affairs |
2,653 | $0 | 11,536 (Direct) |
View |
2023-03-15 Exercise |
2023-03-17 6:21 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
4,790 | $0 | 32,546 (Direct) |
View |
2023-03-15 Exercise |
2023-03-17 6:20 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer |
4,462 | $0 | 26,260 (Direct) |
View |
2023-03-15 Exercise |
2023-03-17 6:18 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Trevejo Jose M. Chief Medical Officer |
7,549 | $0 | 31,302 (Direct) |
View |
2023-03-15 Exercise |
2023-03-17 6:17 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
4,790 | $0 | 68,974 (Direct) |
View |